Europe Smart Inhalers Market Outlook and Strategic Insights by 2027

Europe Smart Inhalers Market to 2027 - Regional Analysis and Forecasts by Product (Nebulizers and Inhalers); Disorder (Chronic Obstructive Pulmonary Disease (COPD), and Asthma); End User (Home-Care Settings and Hospitals & Clinics), and Country

Historic Data: 2016-2017 | Base Year: 2018 | Forecast Period: 2019-2027
  • Status : Published
  • Report Code : TIPRE00006804
  • Category : Life Sciences
  • No. of Pages : 111
  • Available Report Formats : pdf-format excel-format
  • Last update date : February 15, 2025
Europe Smart Inhalers Market Outlook and Strategic Insights by 2027
Report Date: February 15, 2025   |   Report Code: TIPRE00006804 Email: sales@theinsightpartners.com

2018 Market Size

US$ 302.40 Mn

Base year value

2027 Forecast

US$ 2,129.61 Mn

Projected by 2027

CAGR 2019-2027

24.9 %

Growth rate

Addressable Market

US$ 9,703.50 Mn

(2019-2027)

The Europe smart inhalers market is expected to reach US$ 2,129.61 Mn in 2027 from US$ 302.40 Mn in 2018. The market is estimated to grow with a CAGR of 24.9% from 2019-2027.

The growth of the smart inhalers market is driven by the factors such as, growing geriatric population rising prevalence of COPD and asthma, along with rising awareness regarding the medical condition. However, the market is likely to get impacted due to risks associated with cyber threats limited knowledge regarding the use of smart inhalers.

With rapid urbanization there has been growth in various adverse factors that have led to the growth of respiratory diseases across the Europe. Some of the factors leading to growth in the number of asthma and COPD cases across the Europe are rise in air pollution levels and increasing smoking habits.

The rise in air pollution levels has been a matter of rising concern in developed as well as developing economies. As per data published by the World Health Organization (WHO) released during May 2018, 9 out of 10 individuals are believed to breathe air containing high levels of pollutants. Data published by WHO reveals that approximately 7 million people die every year due to exposure to fine particles present in polluted air, which penetrate deep into lungs and the cardiovascular system. This leads to various diseases such as lung cancer, pneumonia, chronic obstructive pulmonary diseases and respiratory infections, among others. Studies reveal, above 90% of air pollution-related deaths worldwide occur in low- and middle-income countries of the Eastern Mediterranean, European regions. According to world health organization (WHO), about 21,000 premature deaths per year in European region because of air pollution like Ozone pollution courses breathe difficulties, triggers asthma symptoms, and causes lung and heart diseases. Additionally increasing indirect effects of air pollution like growing climate change, because of transport is the fastest growing source of fossil-fuel emissions of carbon dioxide (CO2) which is a largest contributor of the climate change. As per data published by World Health Organization (WHO) Some 40 million people in the 115 largest cities in the European Union (EU) are exposed to air exceeding WHO air quality guideline values for at least one pollutant. Children living near roads with heavy-duty vehicle traffic have twice the risk of respiratory problems as those living near less congested streets. Hence, the rising levels of air pollution coupled is anticipated to drive the demand for smart inhalers market during the forecast period.

In 2018, the inhalers segment held a largest market share of the smart inhalers market, by product. The inhalers is expected to dominate its market share in 2027 owing to the increasing mortality rate of asthma. The inhalers segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.

UK is expected to lead the market in the Europe region because the growing prevalence of asthma and COPD Across the country. According to the data published in Asthma UK, in 2016 to 2017 there were 77,124 admissions to hospital for asthma in the UK and in 2017 1,484 people in the UK died from an asthma attack in the UK. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Europe region during the forecast period.

Italy Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

TIPRE00006804-img1
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

EUROPE SMART INHALERS - MARKET SEGMENTATION

By Product

  • Inhalers
  • Nebulizers

By Disorder

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)

By End User

  • Home-care Settings
  • Hospitals & Clinics

By Geography

  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy

Company Profiles

  • GlaxoSmithKline plc
  • Adherium Ltd.
  • Vectura Group plc
  • Novartis AG
  • Findair Sp. z o. o.
  • Cohero Health
  • Crux Product Design Ltd
  • Teva Pharmaceuticals
  • 3M
  • Amiko Digital Health Limited

Europe Smart Inhalers Report Scope

Report Attribute Details
Market size in 2018 US$ 302.40 Million
Market Size by 2027 US$ 2,129.61 Million
CAGR (2019 - 2027) 24.9%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Product
  • Nebulizers
  • Inhalers
By Disorder
  • Chronic Obstructive Pulmonary Disease
  • Asthma
By End User
  • Home-Care Settings and Hospitals & Clinics
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • GlaxoSmithKline plc
  • Adherium Ltd.
  • Vectura Group plc
  • Novartis AG
  • Findair Sp. z o. o.
  • Cohero Health
  • Crux Product Design Ltd
  • Teva Pharmaceuticals
  • 3M
  • Amiko Digital Health Limited
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA